Procter & Gamble has delivered a steady 5 year return while continuing to invest in areas like wellness and sustainable packaging. This puts the focus squarely on what its cash flows are worth today. With the stock recently closing at US$148.41, the live question is whether that price lines up with what the business can generate for shareholders over time.
The issue now is whether the intrinsic value suggested by the Discounted Cash Flow (DCF) estimate can justify where Procter & Gamble shares trade today.
If you want a broader starting point for cash flow focused research beyond Procter & Gamble, you can run the same test across 27 high quality undervalued stocks.
The Discounted Cash Flow (DCF) approach here projects what Procter & Gamble could return to shareholders in future and then brings those dollars back to today. Latest twelve month free cash flow sits at about $15.6b, and the model assumes this stream grows gradually over the next decade rather than swinging sharply higher or lower.
Those steady projections, combined with a 2 Stage Free Cash Flow to Equity framework, lead to an estimated intrinsic value that the model suggests is meaningfully above the current US$148.41 share price. Because the Thorne wellness acquisition and the PaperFlex packaging work both point to ongoing reinvestment needs, the cash flow assumptions already bake in continued spending rather than a bare bones payout profile. That gap between model value and market pricing is what matters for anyone weighing whether Procter & Gamble's current cash generation and projected flows line up with where the shares trade today. Find out what Procter & Gamble could be worth using our Discounted Cash Flow (DCF) estimate.
Narratives for Procter & Gamble pick up where the valuation puzzle leaves off and explain which paths for growth, profitability and earnings would need to occur for the shares to be worth materially more or less than today’s price. All of this is housed on Simply Wall St’s Community page. Instead of a single output from a ratio or DCF model, these narratives describe the future that figure depends on so you can watch over time whether reality stays close to that script.
Community views on Procter & Gamble split between those who see solid fundamentals as enough at roughly today’s valuation and those who think the market is paying too much.
Bull case: roughly fairly valued
"The company maintains a powerful stable of global brands, with non-food consumer staples that carry strong brand loyalty and frequent repeat purchases…"
Discover why this Narrative puts Procter & Gamble at roughly fairly valued.
Bear case: 38% overvalued
"From these simulations we can extrapolate that there''s more than ~90% probability of Procter & Gamble being overvalued…"
Explore why this Narrative puts Procter & Gamble at 38% overvalued.
Valuation tells you what you might be paying for Procter & Gamble, but the research checks also flag specific risk alerts that deserve a closer look before you commit fresh capital. Take a closer look at 2 warning signs before settling on a valuation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com